Found 4750 articles for: "Ted Rosen/page/92/ht...<br><a class=/ht...<br><a class="
INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema
October 2025 | Volume 24 | Issue 10 | Supplement Individual Articles | 025412 | Copyright © October 2025
Chronic hand eczema (CHE) affects up to 10% of the general population and is associated with significant physical discomfort, impaired hand function, and reduced quality of life, yet effective lo...
Read MoreINDIVIDUAL ARTICLE: VEHICLES MATTER
October 2025 | Volume 24 | Issue 10 | Supplement Individual Articles | 025411 | Copyright © October 2025
Management of CHE can be complicated by numerous factors, including the possibility that contact irritants or allergens–including occupational exposures–contribute to the condition. Additi...
Read MoreFULL SUPPLEMENT: Time To Get Hands On: Delgocitinib's Promise For Chronic Hand Eczema
October 2025 | Volume 24 | Issue 10 | Department | 025410 | Copyright © October 2025
Despite its prevalence and impact on patients’ lives, treatment options are limited, with many patients showing inadequate response or intolerance to topical corticosteroids and systemic immunos...
Read MoreReal-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months
October 2025 | Volume 24 | Issue 10 | Original Article | 996 | Copyright © October 2025
Background: Dupilumab has demonstrated benefits in patients with atopic dermatitis (AD), but there is limited information on real-world rates of dupilumab persistence and supplem...
Read MoreSAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare
October 2025 | Volume 24 | Issue 10 | Original Article | 1012 | Copyright © October 2025
Background: Atopic dermatitis (AD) is a common heterogeneous disorder that typically starts in infancy and early childhood, is associated with the development of comorbidities, a...
Read MoreSkin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin
October 2025 | Volume 24 | Issue 10 | Original Article | 1029 | Copyright © October 2025
Background: A novel topical cream moisturizer was designed to deliver immediate and long-lasting skin barrier improvements and to improve skin tolerability when used as adjunctiv...
Read MoreAn Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair
October 2025 | Volume 24 | Issue 10 | Original Article | 988 | Copyright © October 2025
Thinning hair affects the quality of life of affected men and women but has limited treatment options. A novel technology refines exosomes from stem cells to create a concentrated complex that is...
Read MoreEvaluating Topical Nitric Oxide Formulations Against an Atopic Dermatitis Methicillin-Resistant S. Aureus Isolate in a Porcine Infection Model
October 2025 | Volume 24 | Issue 10 | Original Article | 1003 | Copyright © October 2025
Background: Atopic dermatitis (AD) is a skin disorder characterized by reduced skin barrier function, which often leads to recurring infections, predominantly by Staphylococcus a...
Read MoreIncreased Risk of Subcutaneous Nodules and Lipomas Following Influenza Vaccination: A Multicenter TriNetX Cohort Study
October 2025 | Volume 24 | Issue 10 | Original Article | 974 | Copyright © October 2025
Background: Influenza vaccination represents one of the most widespread public health interventions. Localized cutaneous reactions, including nodules and pruritus, may occur rare...
Read MoreThe Emerging Role of Oncodermatology in a Hemato-Oncology Unit in a Tertiary Hospital
October 2025 | Volume 24 | Issue 10 | Original Article | 1018 | Copyright © October 2025
Background: Our dermatology department consistently receives the largest proportion of internal on-call referrals from the Hematology-Oncology Department. Individuals with hemato...
Read More1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use
October 2025 | Volume 24 | Issue 10 | Original Article | 979 | Copyright © October 2025
Background and Objective: Atopic dermatitis (AD) affects 15% to 20% of children. Evidence supporting the effectiveness of colloidal oatmeal-based moisturizers in improving mild-t...
Read MoreRuxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Original Article | 1036 | Copyright © October 2025
Atopic dermatitis (AD), a chronic inflammatory skin disease, is typically treated with topical corticosteroids in patients with mild to moderate disease, creating an ongoing need for nonsteroidal...
Read MoreExamining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin
October 2025 | Volume 24 | Issue 10 | Features | 1046 | Copyright © October 2025
Skin rejuvenation treatments, including chemical peels and biostimulatory therapies, aim to improve facial aging concerns. However, these treatments have limitations, including efficacy, safety, ...
Read MoreThe Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Case Reports | 1043 | Copyright © October 2025
Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report
October 2025 | Volume 24 | Issue 10 | Case Reports | 1041 | Copyright © October 2025
A Qualitative Assessment of Chatbots for Common Dermatologic Conditions
October 2025 | Volume 24 | Issue 10 | Editorials | e60 | Copyright © October 2025
Understanding Topical Steroid Withdrawal: Where Are We Now?
October 2025 | Volume 24 | Issue 10 | Features | 1057 | Copyright © October 2025
Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Editorials | e62 | Copyright © October 2025
The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart Review
October 2025 | Volume 24 | Issue 10 | Features | 1054 | Copyright © October 2025
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia
October 2025 | Volume 24 | Issue 10 | Editorials | e59 | Copyright © October 2025
Media and other results for: "Ted Rosen/page/92/ht...<br><a class=/ht...<br><a class="
No results found
© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
